Indications and uses
for the treatment of acne dries up acne pimples helps prevent new acne pimples.
CLENZIDERM NORMAL TO OILY SKIN
- Manufacturer
- OMP, INC. | PURETEK CORPORATION | Ei INC.
- Effective date
- 2012-05-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:31:56
Label at a glance#
ProductCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM
Active ingredientSALICYLIC ACID, BENZOYL PEROXIDE
Label structure29 sections
Dosage and administration
use AM and PM wet face gently massage product all over face for 20–30 seconds avoiding eye area rinse thoroughly and pat dry wait 10–15 minutes to allow skin to dry completely.
Storage and handling
store away from heat and direct sunlight store at controlled room temperature: 15°–25°C (59°–77°F).
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Daily Care Foaming Cleanser
DRUG FACTS
Active Ingredient
Salicylic Acid 2%
Purpose
Acne treatment gel
Uses
- for the treatment of acne
- dries up acne pimples
- helps prevent new acne pimples.
Warnings
OTC - DO NOT USE SECTION
For external use only.
When using this product
- using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.
Stop use and ask a doctor if
- irritation becomes severe.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- use AM and PM
- wet face
- gently massage product all over face for 20–30 seconds avoiding eye area
- rinse thoroughly and pat dry
- wait 10–15 minutes to allow skin to dry completely.
Other Information
- store away from heat and direct sunlight
- store at controlled room temperature: 15°–25°C (59°–77°F).
Inactive Ingredients
Butyl Avocadate, Cetyl Hydroxyethylcellulose, Cocamidopropyl Betaine, Disodium EDTA, Ethoxydiglycol, Ext. Violet 2 (CI 60730), Fragrance, Menthol, Menthyl Lactate, Sodium Laureth Sulfate, Sodium Lauryl Sulfate, Water (Aqua).
Questions?
(800) 636-7546 Mon–Fri 9:00 am–4:00 pm Pacific Time
SPL UNCLASSIFIED SECTION
Pore Therapy
DRUG FACTS
Active Ingredient
Salicylic Acid 2%
Purpose
Acne treatment
Uses
- for the treatment of acne
- dries up acne pimples
- helps prevent new acne pimples.
Warnings
OTC - DO NOT USE SECTION
For external use only.
When using this product
- using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.
Stop use and ask a doctor if
- irritation becomes severe.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- cleanse the skin thoroughly before applying medication
- cover the entire affected area with a thin layer one to three times daily
- because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Other Information
- store away from heat and direct sunlight
- store at controlled room temperature: 15°–25°C (59°–77°F).
Inactive Ingredients
Benzalkonium Chloride, Benzyl Alcohol, Ethoxydiglycol, Ext. Violet 2 (CI 60730), Fragrance, Glycerin, Menthol, Menthoxypropanediol, Menthyl Lactate, SD Alcohol 40-B (Alcohol Denat.), Water (Aqua).
Questions?
(800) 636-7546 Mon–Fri 9:00 am–4:00 pm Pacific Time
SPL UNCLASSIFIED SECTION
Therapeutic Lotion
DRUG FACTS
Active Ingredient
Benzoyl Peroxide 5%
Purpose
Acne treatment lotion
Uses
- for the treatment of acne
- dries up acne pimples
- helps prevent new acne pimples.
Warnings
OTC - DO NOT USE SECTION
For external use only.
Stop use and ask a doctor if
- irritation becomes severe.
When using this product
- skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time
- avoid unnecessary sun exposure and use a sunscreen
- avoid contact with the eyes, lips, and mouth
- avoid contact with hair and dyed fabrics, which may be bleached by this product
- skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration
- if pregnant or breast-feeding, ask a health care professional before use.
Do not use if you
- have very sensitive skin
- are sensitive to benzoyl peroxide.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- clean the skin thoroughly before applying this product
- cover the entire affected area with a thin layer one to three times daily
- because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day
- if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
Other Information
- store away from heat and direct sunlight
- store at controlled room temperature: 15°–25°C (59°–77°F).
Inactive Ingredients
Benzyl Benzoate, BHT, Dicaprylyl Ether, Dimethyl Isosorbide, Disodium EDTA, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Phenoxyethanol, Polysorbate 60, Propylene Glycol, Squalane, Water (Aqua).
Questions?
1-800-636-7546 Mon–Fri 9:00 am–4:00 pm PST
SPL UNCLASSIFIED SECTION
Distributed by OMP, Inc., Long Beach, CA 90806
PRINCIPAL DISPLAY PANEL - Kit Carton
OBAGI®
CLENZIderm M.D.™
ACNE THERAPEUTIC SYSTEM
- Daily Care Foaming Cleanser
- Pore Therapy
- Therapeutic Lotion
Normal to Oily Skin
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 106309 | benzoyl peroxide 5 % Topical Lotion | PSN | 1 |
| 1236624 | Clenziderm Lotion 5 % Topical Lotion | PSN | 1 |
| 1235205 | CLENZIderm M.D. 2 % Medicated Liquid Soap | PSN | 1 |
| 1235208 | CLENZIderm M.D. 2 % Pore Therapy Topical Solution | PSN | 1 |
| 562600 | salicylic acid 2 % Medicated Liquid Soap | PSN | 1 |
| 251577 | salicylic acid 2 % Topical Solution | PSN | 1 |
| 1236624 | benzoyl peroxide 50 MG/ML Topical Lotion [Clenziderm Lotion] | SBD | 1 |
| 1235205 | salicylic acid 20 MG/ML Medicated Liquid Soap [Clenziderm] | SBD | 1 |
| 1235208 | salicylic acid 20 MG/ML Topical Solution [Clenziderm] | SBD | 1 |
| 106309 | benzoyl peroxide 50 MG/ML Topical Lotion | SCD | 1 |
| 562600 | salicylic acid 20 MG/ML Medicated Liquid Soap | SCD | 1 |
| 251577 | salicylic acid 20 MG/ML Topical Solution | SCD | 1 |
| 106309 | benzoyl peroxide 5 % Topical Lotion | SY | 1 |
| 1235205 | Clenziderm 20 MG/ML Medicated Liquid Soap | SY | 1 |
| 1235208 | Clenziderm 20 MG/ML Topical Solution | SY | 1 |
| 1236624 | Clenziderm Lotion 5 % Topical Lotion | SY | 1 |
| 1236624 | Clenziderm Lotion 50 MG/ML Topical Lotion | SY | 1 |
| 1235205 | Clenziderm M.D. 2 % Daily Care Cleanser | SY | 1 |
| 1235208 | Clenziderm M.D. 2 % Pore Therapy | SY | 1 |
| 562600 | salicylic acid 2 % Facial Cleanser Toner | SY | 1 |
| 562600 | salicylic acid 2 % Facial Scrub | SY | 1 |
| 562600 | salicylic acid 2 % Medicated Liquid Soap | SY | 1 |
| 251577 | salicylic acid 2 % Topical Solution | SY | 1 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a46239a7-5963-4008-8cbb-6b9000f497eb | Product name | 1 | 20250721 |
| b382b4e1-6b48-45f6-bffc-e61b00b0ce19 | Product name | 3 | 20250317 |
| d9d61457-6a5a-41fc-b418-e5479a2904b7 | Product name | 2 | 20230303 |
| 32012d5c-25ac-49c7-9d4c-1313177fff7c | Product name | 1 | 20230112 |
| 13e7e7e3-e885-4c79-af6d-dad1aedbb06e | Product name | 1 | 20220128 |
| 4a7d44fe-774d-404b-aad0-8a90fe78375a | Product name | 4 | 20211025 |
| 3f45980c-c196-47e5-0e5e-48b7c57327c5 | Product name | 5 | 20200428 |
| d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b | Product name | 3 | 20200203 |
| ee5c6de5-d9cd-454f-b250-7b19e5cf2992 | Product name | 4 | 20190619 |
| ad75fcfd-a339-42a1-9c60-43ba2c654cfa | Product name | 1 | 20170810 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62032-511-02 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c3d7-f6ea-e053-dbdaa90aa703 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-110-60 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 mL | 20 mg in 1mL | 1 |
| 62032-111-60 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 mL | 20 mg in 1mL | 1 |
| 62032-113-65 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM | 47 mL in 1 BOTTLE, PLASTIC | LOTION | 47 mL | 50 mg in 1mL | 1 |
| 62032-511-02 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM | 1 in 1 CARTON | KIT | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62032-110 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.] | 1 | Legacy NDC | 20120518_934ec314-1ab7-45ee-a2fe-8bff3ff981b6.zip |
| 62032-111 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.] | 1 | Legacy NDC | 20120518_934ec314-1ab7-45ee-a2fe-8bff3ff981b6.zip |
| 62032-113 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.] | 1 | Legacy NDC | 20120518_934ec314-1ab7-45ee-a2fe-8bff3ff981b6.zip |
| 62032-511 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.] | 1 | Legacy NDC, 4 package rows | 20120518_934ec314-1ab7-45ee-a2fe-8bff3ff981b6.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BENZOYL PEROXIDE | ACTIVE INGREDIENT | W9WZN9A0GM | 1 | |
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| BENZOYL PEROXIDE | ACTIVE MOIETY | W9WZN9A0GM | 1 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| 3-((L-MENTHYL)OXY)PROPANE-1,2-DIOL | INACTIVE INGREDIENT | KD6TZ2QICH | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | 1 | |
| BENZYL BENZOATE | INACTIVE INGREDIENT | N863NB338G | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| CETYL HYDROXYETHYLCELLULOSE (350000 MW) | INACTIVE INGREDIENT | T7SWE4S2TT | 1 | |
| COCAMIDOPROPYL BETAINE | INACTIVE INGREDIENT | 5OCF3O11KX | 1 | |
| DICAPRYLYL ETHER | INACTIVE INGREDIENT | 77JZM5516Z | 1 | |
| DIETHYLENE GLYCOL MONOETHYL ETHER | INACTIVE INGREDIENT | A1A1I8X02B | 1 | |
| DIMETHYL ISOSORBIDE | INACTIVE INGREDIENT | SA6A6V432S | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| EXT. D&C VIOLET NO. 2 | INACTIVE INGREDIENT | G5UX3K0728 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| MENTHOL | INACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| MENTHYL LACTATE, (-)- | INACTIVE INGREDIENT | 2BF9E65L7I | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYSORBATE 60 | INACTIVE INGREDIENT | CAL22UVI4M | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| SODIUM LAURETH SULFATE | INACTIVE INGREDIENT | BPV390UAP0 | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 1 | |
| SQUALANE | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM
- SALICYLIC ACID AND BENZOYL PEROXIDE
- CLENZIDERM DAILY CARE FOAMING CLEANSER ACNE TREATMENT
- SALICYLIC ACID
- SODIUM LAURETH SULFATE
- DIETHYLENE GLYCOL MONOETHYL ETHER
- SODIUM LAURYL SULFATE
- COCAMIDOPROPYL BETAINE
- CETYL HYDROXYETHYLCELLULOSE (350000 MW)
- EDETATE DISODIUM
- MENTHOL
- MENTHYL LACTATE, (-)-
- EXT. D&C VIOLET NO. 2
- WATER
- CLENZIDERM PORE THERAPY ACNE TREATMENT
- ALCOHOL
- BENZYL ALCOHOL
- 3-((L-MENTHYL)OXY)PROPANE-1,2-DIOL
- GLYCERIN
- BENZALKONIUM CHLORIDE
- CLENZIDERM THERAPEUTIC
- BENZOYL PEROXIDE
- BENZYL BENZOATE
- DICAPRYLYL ETHER
- PROPYLENE GLYCOL
- SQUALANE
- POLYSORBATE 60
- DIMETHYL ISOSORBIDE
- PHENOXYETHANOL
- BUTYLATED HYDROXYTOLUENE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62032-511 | 62032-511-02 |
| 62032-111 | 62032-111-60 |
| 62032-110 | 62032-110-60 |
| 62032-113 | 62032-113-65 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, EFFERVESCENT / ORAL | 1.5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / AURICULAR (OTIC) | 0 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOAP / TOPICAL | 0.75 %w/w | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | LOTION / TOPICAL | 5 %w/w | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | LOTION / TOPICAL | 111 mg | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | SUPPOSITORY / RECTAL | 0.05 mg/mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY, METERED / NASAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / AURICULAR (OTIC) | ADJ PH | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / SUBLINGUAL | 36 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CREAM / TOPICAL | 214 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRA-ARTICULAR | 1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | INHALANT / NASAL | 32 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | TABLET, DELAYED RELEASE / ORAL | 2.31 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, CHEWABLE / ORAL | 6 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / SUBCUTANEOUS | 1.4 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | INSERT / VAGINAL | 15 mg | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | GEL / TRANSDERMAL | 87 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | POWDER / VAGINAL | 3 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SHAMPOO / TOPICAL | 1.25 %w/w | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | OINTMENT / TOPICAL | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | OINTMENT / TOPICAL | 57 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | FILM, SOLUBLE / ORAL | 0.06 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TAMPON / VAGINAL | 62.1 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | SHAMPOO / TOPICAL | 65 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / TOPICAL | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | GEL / TOPICAL | 0.05 %w/w | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | GEL / TOPICAL | 2500 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUPPOSITORY / VAGINAL | 252 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / RESPIRATORY (INHALATION) | 25 %w/w | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / TOPICAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TRANSDERMAL | 500 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / AURICULAR (OTIC) | 10 %w/v | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | INJECTION / INTRAMUSCULAR | 1500 mg | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | SOLUTION / INTRAMUSCULAR | 447 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c048c2d1-4ebd-49dd-a8e4-0c374cd20c1e | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 2012-05-10 | Warnings | c048c2d1-4ebd-49dd-a8e4-0c374cd20c1e 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.